Vaccines, Subunit
- Name
- Vaccines, Subunit
- Accession Number
- DBCAT005204
- Description
Not Available
- Drugs
Drug Drug Description VEGFR2-169 VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)). - Drugs & Drug Targets
Drug Target Type